openPR Logo
Press release

Phytochemical API Market With Major Key Companies Arboris LLC, Cargill, Indo Phytochem Pharmaceuticals., and BASF SE

02-28-2019 07:18 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Phytochemical API

Phytochemical API

Phytochemical APIs are active chemical compounds extracted from plants with the help of semi-synthetic procedures and possess medicinal properties. Phytochemicals are divided into two categories such as primary and secondary constituents. Primary phytochemicals includes chlorophyll, proteins, sugar, and amino acids, while secondary constituents contain terpenoids and alkaloids. Phytochemical API plays an important role in pharmaceutical companies for the production of new drugs for curing various diseases.

Global Phytochemical API Market Drivers

Increasing preferences of herbal medicines over allopathic drugs is expected to boost growth of the phytochemical API market. Moreover, increasing initiatives by pharmacognosy research to develop drugs containing natural chemical compounds is another factor to drive the phytochemical API market growth. For instance, in 2017, as per new research paper published in the Journal of Natural Compounds, International Cooperative Biodiversity Group discovered new chemical, Patentiflorin A, which is derived from willow-leaved Justicia. Patentiflorin A could inhibit the action of reverse transcriptase much more effectively than Azidothymidine (AZT). AZT is an antiretroviral medication used to prevent and treat HIV/AIDS. Patentiflorin A acts as a novel anti-HIV agent that can be used with current anti-HIV drugs to suppress the activity of HIV virus and prevent AIDS.

However, availability of prominent allopathic drugs to cure disease conditions in lesser time interval than herbal drugs is expected to hinder the growth of phytochemical API market.

Get HOLISTIC Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2492

Global Phytochemical API Market - Regional Analysis

On the basis of region, the global phytochemical API market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to witness conducive growth for phytochemical API market, owing to increasing number of pipeline studies to develop medications containing active chemical compounds extracted from plants. For instance, in August 2018, University of Michigan initiated phase 2/phase 3 clinical trial for colchicine, to study the effect of postoperative treatment of colchicine in Fontan patients. Colchicine, an anti-inflammatory agent, is a toxic alkaloid and secondary metabolite extracted from plants of the genus Colchicum. The study is estimated to complete by June 2020.

Moreover, keys player in Europe are focused on adopting business strategies such as acquisitions and collaborations in order to strengthen its business, which is expected to show significant growth for phytochemical API market in the region. For instance, in 2014, Centroflora CMS, Luxembourg-based pharmaceutical group, acquired phytochemical API product portfolio from Boehringer Ingelheim. The company signed a multi-year exclusive agreement with Boehringer Ingelheim to supply phytochemical APIs products in the market. The acquired product portfolio includes chemical compounds such as atropine and atropine sulfate, digoxin, and digoxin micron, along with metildigoxin, homatropine methylbromide, homatropine hydrobromide, and dihydroergotamine mesylate.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2492

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phytochemical API Market With Major Key Companies Arboris LLC, Cargill, Indo Phytochem Pharmaceuticals., and BASF SE here

News-ID: 1622640 • Views: 338

More Releases from Coherent Market Insights

Explosive Detection Technologies Market 2022 Growth, Share, Strategies And Globa …
According to research published by CMI, the Explosive Detection Technologies Market is estimated to be worth US$ 11,445.2 Million by 2027, with a CAGR of 7.0 % over the forecast period (2019-2027). Explosive Detection Technologies Market 2022-2027 research report from Coherent Market Insights examines the market's flow state and key components to provide an in-depth look at the market. It accurately sends important data and cutting-edge analysis to help establish a
Zero Liquid Discharge Market 2022 Insights, Share, Trends With Global Opportunit …
According to research published by Coherent Market Insights, the Zero Liquid Discharge Market is estimated to be worth US$ 1,253.08 million by 2027, with a CAGR of 8.7% over the forecast period (2019-2027). The Zero Liquid Discharge 2022-2027 research report from Coherent Market Insights examines the market's flow state and key components to provide an in-depth look at the market. It accurately sends important data and cutting-edge analysis to help establish
Refrigerated Trailer Market 2022 - Industry Share, Challenges, Opportunities And …
According to the CMI report, The global refrigerated trailer market is predicted to reach US$ 1,801.00 Million in 2019 and grow at a CAGR of 5.4 % over the next five years. This in-depth analysis of the Refrigerated Trailer Market contains comprehensive market figures as well as information on the present state of the global and regional markets. Its comprehensive study covers everything from market circumstances to pricing comparisons among big corporations,
Photonic IC Market 2022: Development Trends And Global Opportunities Forecast to …
According to a report published by Coherent Market Insights, the Photonic IC Market is estimated to be worth US$ 17,075.6 million by 2027, with a CAGR of 42.6 % over the forecast period (2020-2027). This in-depth analysis of the Photonic IC Market contains comprehensive market figures as well as information on the present state of the global and regional markets. Its comprehensive study covers everything from market circumstances to pricing comparisons

All 5 Releases


More Releases for API

Terminating Twitter API Integrations
Thexyz Inc, the leading private email service that protects people and their data announces that a Twitter authentication apps developed by Thexyz will be discontinued and no longer supported. Thexyz focuses on security, privacy, freedom, and an open internet that respects the rights of individuals. It is a goal to work with organizations that share these values and discontinue support for services that do not. Thexyz has developed applications
Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The